A Study of SGB-3383 in Healthy Subjects

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) effects of SGB-3383 in healthy subjects. The study will be designed as a single ascending dose (SAD) phase, utilizing a double-blind, placebo-controlled approach.
Epistemonikos ID: 88d7bf34dee4f80211fed3fae5b4aa3f4599a275
First added on: May 31, 2025